Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Intravitreal bevacizumab in choroidal neovascularization secondary to Grönblad-Strandberg syndrome: case report.

Japiassú RM, Japiassú MA, Pecego MG.

Arq Bras Oftalmol. 2008 May-Jun;71(3):427-9.

2.

Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.

Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C.

Arch Ophthalmol. 2007 Oct;125(10):1422-3. No abstract available.

PMID:
17923555
3.

Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up.

Schiano Lomoriello D, Parravano MC, Chiaravalloti A, Varano M.

Eur J Ophthalmol. 2009 Jan-Feb;19(1):151-3.

PMID:
19123166
4.

Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum : a severe systemic adverse event after an off-label procedure.

Besozzi G, Ferrara A, Epifani E, Intini D, Apruzzese M, Provenzano A, Vetrugno M.

Int Ophthalmol. 2013 Apr;33(2):181-3. doi: 10.1007/s10792-012-9647-9. Epub 2012 Oct 14.

PMID:
23065017
5.

The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).

Derriman L, Marshall J, Moorman C, Downes SM.

Retina. 2008 Jun;28(6):910; author reply 910-1. doi: 10.1097/IAE.0b013e31816d81d0. No abstract available.

PMID:
18536613
6.

[Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: a report of 2 cases].

González-Gómez A, Morillo MJ, González-Escobar AB, García-Campos JM.

Arch Soc Esp Oftalmol. 2012 May;87(5):153-6. doi: 10.1016/j.oftal.2011.06.015. Epub 2012 Mar 19. Spanish.

PMID:
22554559
7.

Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.

Myung JS, Bhatnagar P, Spaide RF, Klancnik JM Jr, Cooney MJ, Yannuzzi LA, Freund KB.

Retina. 2010 May;30(5):748-55. doi: 10.1097/IAE.0b013e3181c596b1.

PMID:
19996818
8.

Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.

Bhatnagar P, Freund KB, Spaide RF, Klancnik JM Jr, Cooney MJ, Ho I, Fine HF, Yannuzzi LA.

Retina. 2007 Sep;27(7):897-902.

PMID:
17891014
9.

An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report.

Karampelas M, Soumplis V, Karagiannis D, Parikakis E, Webster AR.

BMC Res Notes. 2013 Dec 11;6:530. doi: 10.1186/1756-0500-6-530.

10.

[Angioid streaks complicated by choroidal neovascularization secondary to pseudoxanthoma elasticum: diagnosis and treatment. Case report].

Maalej A, Ouederni M, Khallouli A, Gabsi S.

J Fr Ophtalmol. 2012 Dec;35(10):803-8. doi: 10.1016/j.jfo.2012.06.013. Epub 2012 Oct 22. French.

11.

[Subretinal neovascular membrane in angioid streaks treated with intravitreal bevacizumab].

García-López A, González-Castaño C.

Arch Soc Esp Oftalmol. 2014 May;89(5):203-6. doi: 10.1016/j.oftal.2012.11.010. Epub 2013 Apr 3. Spanish.

PMID:
24269464
12.

Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.

Kovach JL, Schwartz SG, Hickey M, Puliafito CA.

Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):77-9.

PMID:
19205505
13.

The effect of treatments given to patients before initiation of anti-vascular endothelial growth factor treatment.

Hedaya J, Freeman WR.

Retina. 2008 Jun;28(6):911-2; author reply 912. doi: 10.1097/IAE.0b013e3181733746. No abstract available.

PMID:
18536615
14.

Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.

Teixeira A, Moraes N, Farah ME, Bonomo PP.

Acta Ophthalmol Scand. 2006 Dec;84(6):835-6. No abstract available.

15.

Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.

Finger RP, Charbel Issa P, Schmitz-Valckenberg S, Holz FG, Scholl HN.

Retina. 2011 Jul-Aug;31(7):1268-78. doi: 10.1097/IAE.0b013e318207d1dc.

PMID:
21386758
16.

Successful long-term management of choroidal neovascularization secondary to angioid streaks in a patient with pseudoxanthoma elasticum: a case report.

Savastano MC, Minnella AM, Zinzanella G, Falsini B, Caporossi A.

J Med Case Rep. 2014 Dec 22;8:458. doi: 10.1186/1752-1947-8-458.

17.

Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S.

Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1707-10.

PMID:
19916212
18.

Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks.

Apte RS.

Eye (Lond). 2008 May;22(5):734-5. doi: 10.1038/sj.eye.6702941. Epub 2008 Mar 14. No abstract available.

PMID:
18344971
19.

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum: five-year follow-up.

Zebardast N, Adelman RA.

Semin Ophthalmol. 2012 May-Jul;27(3-4):61-4. doi: 10.3109/08820538.2012.680644.

PMID:
22784267
20.

[Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks].

Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D.

Ophthalmologe. 2007 Apr;104(4):325-8. German.

PMID:
17334745
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk